135 related articles for article (PubMed ID: 16024966)
21. Use of early postoperative MAG3 renal scan to predict long-term outcomes of renal transplants.
Park UJ; Kim HT; Cho WH; Kim MY; Hwang EA; Han SY; Park SB; Kim HC; Zeon SK
Exp Clin Transplant; 2013 Apr; 11(2):118-21. PubMed ID: 23477352
[TBL] [Abstract][Full Text] [Related]
22. Periaortitis complicating chronic aortic dissection.
Johnston PW; Kennedy PT; Blair PH
Eur Heart J; 2007 Feb; 28(4):442. PubMed ID: 16952924
[No Abstract] [Full Text] [Related]
23. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
Afshan A; Sohaib M; Jehangir M
Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
[TBL] [Abstract][Full Text] [Related]
24. The role of technetium-99m MAG3 renal imaging in the diagnosis of acute tubular necrosis of native kidneys.
Blaustein DA; Myint MM; Babu K; Avram MM; Chandramouli BS
Clin Nucl Med; 2002 Mar; 27(3):165-8. PubMed ID: 11852301
[TBL] [Abstract][Full Text] [Related]
25. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
26. A simple method for determining split renal function from dynamic (99m)Tc-MAG3 scintigraphic data.
Wesolowski MJ; Conrad GR; Šámal M; Watson G; Wanasundara SN; Babyn P; Wesolowski CA
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):550-8. PubMed ID: 26537286
[TBL] [Abstract][Full Text] [Related]
27. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
28. Estimation of differential renal function by means of 99mTc-MAG3: integral method or Rutland-Patlak plot?
Piepsz A; Ham H
Eur J Nucl Med; 1999 Dec; 26(12):1627-8. PubMed ID: 10638417
[No Abstract] [Full Text] [Related]
29. Tc-99m MAG3 scintigraphy in a newborn with acute renal vein thrombosis.
Izquierdo V; Gómez D; Macías E; Gellida J; Siurana R; Moralejo J; de Vírgala CM
Clin Nucl Med; 1999 Apr; 24(4):287-8. PubMed ID: 10466536
[No Abstract] [Full Text] [Related]
30. Initial presentation of scintigraphic changes during the first episode of acute pyelonephritis in children: simultaneous evaluation with MAG3 and DMSA.
Grbac-Ivanković S; Smokvina A; Girotto N; Licul V
Nuklearmedizin; 2007; 46(4):129-34. PubMed ID: 17690790
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
Moran JK
Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
[TBL] [Abstract][Full Text] [Related]
32. U.S. Diagnostic Reference Levels and Achievable Administered Activities for Adult Renal Scintigraphy: An Analysis of the Intersocietal Accreditation Committee Nuclear Laboratories.
Banks KP; Gunther RS; Farrell MB; Peacock JG; Costello M; Gordon LL
J Nucl Med Technol; 2021 Sep; 49(3):246-249. PubMed ID: 33820862
[TBL] [Abstract][Full Text] [Related]
33. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
[TBL] [Abstract][Full Text] [Related]
34. A large renal pelvic diverticulum, presenting incomplete excretion during tc-99m MAG-3 scintigraphy and tracer accumulation on tc-99m DMSA scintigraphy; a case report.
Turgut B; Erselcan T; Ozdemir S; Hasbek Z; Tosun HB; Topaktas S
Ann Nucl Med; 2004 Dec; 18(8):689-93. PubMed ID: 15682850
[TBL] [Abstract][Full Text] [Related]
35. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
36. Intestinal activity on Tc-99m MAG3 scintigraphy in a patient after renal transplant may interfere with interpretation.
Barnes S; Shih WJ; Saylor M
Clin Nucl Med; 2000 Aug; 25(8):643-4. PubMed ID: 10944031
[No Abstract] [Full Text] [Related]
37. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function.
Itoh K
Ann Nucl Med; 2001 Jun; 15(3):179-90. PubMed ID: 11545186
[TBL] [Abstract][Full Text] [Related]
38. Re: Taylor et al.: a 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function (Urology 2010;76:1512-1516).
Zuckier LS
Urology; 2011 Apr; 77(4):1011; author reply 1011-2. PubMed ID: 21477735
[No Abstract] [Full Text] [Related]
39. [Dynamic renal scintigraphy of dissecting aneurysm of abdominal aorta].
Tsukamoto E; Itoh K; Furudate M
Kaku Igaku; 1990 Dec; 27(12):1377-84. PubMed ID: 2290208
[TBL] [Abstract][Full Text] [Related]
40. Scintigraphic evaluation of obstructing primary megaureter with Tc-99m MAG3.
Erbas B; Royal SA; Joseph D
Clin Nucl Med; 1997 Jun; 22(6):355-8. PubMed ID: 9193802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
